Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

URGNURGN
Showing 8 of 30 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in UROGEN PHARMA LTD

Yes. Northern Trust holds 304,570 shares of URGN (Urogen Pharma), worth $11.2M, as of its Q2 2026 13F filing. It increased the position by 28,632 shares (+10.4%) from Q1 2026. Northern Trust has held URGN in every 13F on record since Q1 2019, 30 quarterly filings.

Current Value

$11.2M

Current Shares

304,570

Total Value Change

+$7.6M

Total Shares Change

+17,841

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
304,570
+10.4%
$11.2M0.0%$36.80
31
2026-Q1
Increased
275,938
+16.2%
$5M0.0%$17.98
31
2025-Q4
Decreased
237,457
-9.2%
$5.6M0.0%$23.42
0
2025-Q3
Decreased
261,401
-2.4%
$5.2M0.0%$19.95
0
2025-Q2
Decreased
267,718
-6.3%
$3.7M0.0%$13.70
0
2025-Q1
Decreased
285,614
-7.9%
$3.2M0.0%$11.06
0
2024-Q4
Increased
310,074
+8.1%
$3.3M0.0%$10.65
29
2024-Q3
Increased
286,729
+31.9%
$3.6M0.0%$12.70
34

Other major holders of URGN: RTW INVESTMENTS, LP, BlackRock, Inc., MENORA MIVTACHIM HOLDINGS LTD.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used